Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
NCT02727335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 318
Last updated 2023-05-24
Summary
Description of clinical and anatomical features and long-term follow-up for patients with ALK rearrangement and treated by crizotinib
Conditions
- Non-small Cell Lung Cancer
- Anaplastic Lymphoma Kinase Gene Mutation
Sponsors & Collaborators
-
Intergroupe Francophone de Cancerologie Thoracique
lead OTHER
Principal Investigators
-
Denis Moro-Sibilot · Intergroupe Francophone de Cancerologie Thoracique
-
Michael Duruisseaux · Intergroupe Francophone de Cancerologie Thoracique
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- France
Study Locations
More Related Trials
-
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
NCT01366170 ·Status: COMPLETED
-
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
NCT04213664 ·Status: UNKNOWN
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma
NCT05934045 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients
NCT02010047 ·Status: COMPLETED ·Phase: NA
-
Immune and Genomic Markers in ALK+ NSCLC
NCT04881916 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression
NCT01075360 ·Status: COMPLETED
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING
-
Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
NCT06924463 ·Status: RECRUITING
-
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
NCT02273336 ·Status: COMPLETED
-
Studying Tumor Samples From Young Patients With Neuroblastoma
NCT00907920 ·Status: COMPLETED
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
NCT05983172 ·Status: ENROLLING_BY_INVITATION
-
Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)
NCT02570100 ·Status: TERMINATED ·Phase: NA
-
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
NCT01563874 ·Status: COMPLETED
-
Genetic Characterisation of High-grade Paediatric Osteosarcomas
NCT00223184 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00026910 ·Status: COMPLETED
-
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer
NCT00963326 ·Status: UNKNOWN